KYMR
$104.78-3.11%
Kymera Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.01%Russell 3000 0.010%
Kymera Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Kymera Therapeutics Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $77.81 | $104.78 | 0.0% | +34.7% | |
| 2025 | $40.23 | $77.81 | 0.0% | +93.4% | |
| 2024 | $25.46 | $40.23 | 0.0% | +58.0% | |
| 2023 | $24.96 | $25.46 | 0.0% | +2.0% | |
| 2022 | $63.49 | $24.96 | 0.0% | -60.7% | |
| 2021 | $62.00 | $63.49 | 0.0% | +2.4% |
- Annualized
- +21.4%
- 2021–2026
- Average year
- +19.0%
- 5 full years
- Best year
- +93.4%
- 2025
- Worst year
- -60.7%
- 2022
- Positive years
- 4/5
- 80% up
Annualized (CAGR)
+21.4%
2021–2026
Average year
+19.0%
5 full years
Best year
+93.4%
2025
Worst year
-60.7%
2022
Positive years
4/5
80% up
Total return by period#
Annual
-50%0%50%
2021+2.4%'21
2022-61%'22
2023+2.0%'23
2024+58%'24
2025+93%'25
2026+35%'26
Methodology#
Total returns, dividends reinvested, measured on KYMR. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Kymera Therapeutics Inc.'s average annual return?
- Since 2021, Kymera Therapeutics Inc. (KYMR) has returned about 21.4% a year (the compound annual growth rate) and an average calendar-year return of 19.0%.
- What were Kymera Therapeutics Inc.'s best and worst years?
- Over 2021–2026, the best year was 2025 (+93.4%) and the worst was 2022 (-60.7%).
- How often is Kymera Therapeutics Inc. up in a year?
- 4 of the 5 full years since 2021 were positive — about 80% of the time.
More on Kymera Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100